AI · March 28, 2026 · 4 MIN READ
AI News Brief — March 28, 2026
The AI landscape is entering a tri-polar moment: GPT-5.4, Claude 4.6, and Gemini 3.1 are each staking out distinct territory — reasoning, safety, and multimodal depth respectively. Meanwhile, the Arm AGI CPU signals that the hardware race is no longer just about GPUs.
READ BRIEF →
Biotech · March 28, 2026 · 4 MIN READ
Biotech & Longevity Brief — March 28, 2026
The world's first longevity gene therapy entered Phase 1 clinical trials this week, targeting the TERT gene associated with telomere length. Updated cholesterol guidelines shift the entire prevention paradigm from treatment to lifelong management starting in childhood.
READ BRIEF →
Energy · March 28, 2026 · 4 MIN READ
Energy & Infrastructure Brief — March 28, 2026
The Iran conflict is accelerating both nuclear and renewable energy investment globally — a pattern that mirrors how the 1973 oil embargo triggered the first solar energy boom. FluxPoint Energy's uranium conversion plant is the first new U.S. nuclear fuel facility in nearly 70 years.
READ BRIEF →
Robotics · March 28, 2026 · 4 MIN READ
Robotics Brief — March 28, 2026
Figure 03 debuted at the White House this week — the first humanoid robot to appear at a formal government event. Amazon's acquisition of Fauna Robotics signals that last-mile logistics automation is entering its consolidation phase.
READ BRIEF →
Tek-Finds · March 28, 2026 · 3 MIN READ
Tek-Finds Brief — March 28, 2026
Today's five finds span autonomous home robotics, AI-powered metabolic health, edge AI hardware, and next-generation creative tools — each representing a convergence point where technology is making a specific human task meaningfully better.
READ BRIEF →